2022年

Comparison of two families with and without ataxia harboring novel variants in PRKCG
Tada Y, Kume K, Noguchi S, Sekiya T, Nishinaka K, Ishiguchi H, Koh J, Emori S, Nakayama Y, Kurashige T, Izumi Y, Ito H, Sakai N, Kawakami H. Journal of Human Genetics. 28 Jun 2022. doi: 10.1038/s10038-022-01057-6.
Probable progressive supranuclear palsy in a patient with chronic schizophrenia: A case report.
Kita A, Tsuji T, Koh J, Takahashi S, Yamamoto M, Sakamoto Y, Itogawa H, Kimoto S. Experimental and Therapeutic Medicine. 2022 Jun. doi: 10.3892/etm.2022.11411
Late-Onset Dyskinesia Occurring During Antipsychotic Treatment for Schizophrenia: Management of Tardive Dyskinesia Based on the Latest Knowledge
Sakata M, Ito H.
Brain Nerve. 2022 May;74(5):571-574.
Acute eye movement-retained internal ophthalmoplegia in atypical Miller Fisher syndrome variants are associated with IgG anti-GQ1b antibodies.
Murakami K, Miyamoto K, Terayama A, Yoshikawa K, Kuwahara M, Ito H. Journal of Neuroimmunology 2022;368:577880
Acute Oropharyngeal Palsy following Bilateral Adie’s Tonic Pupils Associated with anti-GT1a and GQ1b IgG Antibodies.
Murakami K, Kajimoto Y, Ito H. Intern Med. 2022 Apr 2. doi: 10.2169/internalmedicine.8416-21.
Validation of the Japanese version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease-Rating Scale (QUIP-RS).
Takahashi M, Koh J, Yorozu S, Kajimoto Y, Nakayama Y, Sakata M, Yasui M, Hiwatani Y, Weintraub D, Ito H. Parkinsons Dis. 2022 Mar 23;2022:1503167. doi: 10.1155/2022/1503167
Efficacy and safety of istradefylline in patients with Parkinson's disease presenting with postural abnormalities: Results from a multicenter, prospective, and open-label exploratory study in Japan
Takahashi M, Shimokawa T, Koh J, Takeshima T, Yamashita H, Kajimoto Y, Mori A, Ito H. J Neurol Sci. 2022 Jan 15;432:120078. doi: 10.1016/j.jns.2021.120078.
A single-arm open-label pilot study of brief mindfulness meditation to control impulsivity in Parkinson’s disease
Koh J, Takahashi M, Ohmae Y, Taruya J, Sakata M, Yasui M, Terada M, Ito H. PLoSOne. 2022 Apr 6;17(4):e0266354. doi: 10.1371/journal.pone.0266354.
Schizophrenia after remission of anti-NMDA receptor encephalitis.
Yasuda K, Uenishi S, Sakamoto H, Hori K, Koh J, Takahashi S. Asian J Psychiatr. 12;70:103027, 2022
A case of anti-MOG antibody-positive ADEM following COVID-19 mRNA vaccination
Miyamoto K, Koh J, Niwa M, Takahashi M, Ito H. Neurological Sciences. 19. doi: 10.1007/s10072-022-06019-6, 2022
Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial
Oki R, Izumi Y, Fujita K, Miyamoto R, Nodera H, Sato Y, Sakaguchi S, Nokihara H, Kanai K, Tsunemi T, Hattori N, Hatanaka Y, Sonoo M, Atsuta N, Sobue G, Shimizu T, Shibuya K, Ikeda K, Kano O, Nishinaka K, Kojima Y, Oda M, Komai K, Kikuchi H, Kohara N, Urushitani M, Nakayama Y, Ito H, Nagai, M, Nishiyama K, Kuzume D, Shimohama S, Shimohata T, Abe K, Ishihara T, Onodera O, Isose S, Araki N, Morita M, Noda K, Toda T, Maruyama H, Furuya H, Teramukai S, Kagimura T, Noma K, Yanagawa H, Kuwabara S, Kaji R, ; for the Japan Early-Stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) Collaborators JAMA Neurol. Published online May 9, 2022
SUMO1 Modification of Tau in Progressive Supranuclear Palsy
Takamura H, Nakayama Y, Ito H, Katayama T, Fraser Paul E., Matsuzaki S Molecular Neurobiology. Published online May 14, 2022
Diagnostic utility of susceptibility-weighted imaging in amyotrophic lateral sclerosis.
Yasui M, Koh J, Nakayama Y, Sakata M, Hiwatani Y, Ishiguchi H, Ito H.
J Neurol Sci. 2023 Jan 15;444:120524. doi: 10.1016/j.jns.2022.120524.
An exploratory, open-label, randomized, multicenter trial of hachimijiogan for mild Alzheimer's disease.
Kainuma M, Ouma S, Kawakatsu S, Iritani O, Yamashita KI, Ohara T, Hirano S, Suda S, Hamano T, Hieda S, Yasui M, Yoshiiwa A, Shiota S, Hironishi M, Wada-Isoe K, Sasabayashi D, Yamasaki S, Murata M, Funakoshi K, Hayashi K, Shirafuji N, Sasaki H, Kajimoto Y, Mori Y, Suzuki M, Ito H, Ono K, Tsuboi Y.
Front Pharmacol. 2022 Oct 14;13:991982. doi: 10.3389/fphar.2022.991982.
Suppression of Linear Ubiquitination Ameliorates Cytoplasmic Aggregation of Truncated TDP-43.
Zhang Q, Terawaki S, Oikawa D, Okina Y, Usuki Y, Ito H, Tokunaga F.
Cells. 2022 Aug 3;11(15):2398. doi: 10.3390/cells11152398.
Autoimmune glial fibrillary acidic protein astrocytopathy overlapping with immunoglobulin G anti-GM1 antibody-associated acute motor axonal neuropathy.
Murakami K, Miyamoto K, Hiwatani Y, Kajimoto Y, Ito H.
Neurol Sci. 2022. Nov;43(11):6583-6584. doi: 10.1007/s10072-022-06253-y.
Late-Onset Dyskinesia Occurring During Antipsychotic Treatment for Schizophrenia: Management of Tardive Dyskinesia Based on theLatest Knowledge].
Sakata M, Ito H.
Brain Nerve. 2022 May;74(5):571-574. Japanese. doi:10.11477/mf.1416202082.
Acute Oropharyngeal Palsy Following Bilateral Adie's Tonic Pupils Associated with Anti-GT1a and GQ1b IgG Antibodies.
Murakami K, Kajimoto Y, Ito H. Intern Med. 2022 Oct 15;61(20):3121-3124. doi: 10.2169/internalmedicine.8416-21.

PAGE TOP

AltStyle によって変換されたページ (->オリジナル) /